文献速递神经头颈MR

健康志愿者脑部的锰增强MRI

Manganese-Enhanced MRI of the Brain in Healthy Volunteers.
PubMed 文献 · AJNR Am J Neuroradiol · 2019-08-01

在9名健康成人志愿者中静脉给予锰福地吡(5 μmol/kg,1 mL/min),用3T MRI观察脑及头颈部腺结构的锰增强动态。脉络丛和垂体前叶在输注后10分钟内强化,外分泌腺最早在1小时强化,均无临床不良效应。

要点

  • 锰福地吡增强可无创显示血脑屏障外的颅内和颅外结构,如脉络丛、垂体前叶和外分泌腺。
  • 脉络丛强化持续至7天,垂体前叶强化持续至30天,外分泌腺强化一般在1个月内消退。
  • 锰福地吡未影响临床指标、实验室指标或基底节T1加权信号。

核心结论

  • 锰福地吡释放的锰离子可成功无创显示血脑屏障外的颅内和颅外结构,无临床不良效应,为未来疾病神经影像学研究奠定基础。

研究设计与样本

  • 在9名健康成人志愿者(6男/3女,中位年龄43岁)中静脉给予锰福地吡(1 mL/min,总剂量5 μmol/kg),用3T MRI在给药后即刻至7天多个时间点及1-3个月延迟扫描。

关键影像表现/征象

  • 脉络丛和垂体前叶在输注后10分钟内强化。
  • 脉络丛强化持续达7天,垂体前叶强化持续达30天。
  • 腮腺、下颌下腺、舌下腺和泪腺等外分泌腺最早在给药后1小时明显强化,一般1个月内消退。
  • 3名志愿者外分泌腺残留强化,其中1名2个月内消退,另2名3个月内消退。
  • 锰福地吡未影响基底节T1加权信号。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The manganese ion is used as an intracellular MR imaging contrast agent to study neuronal function in animal models, but it remains unclear whether manganese-enhanced MR imaging can be similarly useful in humans. Using mangafodipir (Teslascan, a chelated manganese-based contrast agent that is FDA-approved), we evaluated the dynamics of manganese enhancement of the brain and glandular structures in the rostral head and neck in healthy volunteers.

MATERIALS AND METHODS: We administered mangafodipir intravenously at a rate of 1 mL/minute for a total dose of 5 μmol/kg body weight. Nine healthy adult volunteers (6 men/3 women; median age, 43 years) completed baseline history and physical examination, 3T MR imaging, and blood work. MR imaging also followed mangafodipir administration at various time points from immediate to 7 days, with delayed scans at 1-3 months.

RESULTS: The choroid plexus and anterior pituitary gland enhanced within 10 minutes of infusion, with enhancement persisting up to 7 and 30 days, respectively. Exocrine (parotid, submandibular, sublingual, and lacrimal) glands also enhanced avidly as early as 1 hour postadministration, generally resolving by 1 month; 3 volunteers had residual exocrine gland enhancement, which resolved by 2 months in 1 and by 3 months in the other 2. Mangafodipir did not affect clinical parameters, laboratory values, or T1-weighted signal in the basal ganglia.

CONCLUSIONS: Manganese ions released from mangafodipir successfully enable noninvasive visualization of intra- and extracranial structures that lie outside the blood-brain barrier without adverse clinical effects, setting the stage for future neuroradiologic investigation in disease.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Sudarshana DM, Nair G, Dwyer JT, et al. Manganese-Enhanced MRI of the Brain in Healthy Volunteers. AJNR Am J Neuroradiol. 2019. PMID: 31371354. doi:10.3174/ajnr.A6152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。